Last reviewed · How we verify
A Randomized,Double-blind,Placebo-Controlled,Multicenter Clinical Trail of Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer
The purpose of this study is to observe quality of life and treatment side effects in patients with advanced non small cell lung cancer (NSCLC) receive chemotherapy and Yangzhengxiaoji capsule.
Details
| Lead sponsor | Shandong Cancer Hospital and Institute |
|---|---|
| Phase | Phase 4 |
| Status | UNKNOWN |
| Enrolment | 520 |
| Start date | 2014-08 |
| Completion | 2016-12 |
Conditions
- Non-Small Cell Lung Cancer
Interventions
- Yangzhengxiaoji Capsule
- Placebo Capsule
Primary outcomes
- Functional Assessment of Cancer Therapy-Lung scale — 84day
- Lung Cancer Symptom Scale — 84day